(Q27640402)

English

The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility

scientific article (publication date: 14 February 2003)

In more languages

Statements

scholarly article

0 references

The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility (English)

0 references

crystal structure

0 references

author name string

Jennifer A Carmichael

1

0 references

Barbara E Power

2

0 references

Thomas P J Garrett

3

0 references

Paul J Yazaki

4

0 references

John E Shively

5

0 references

Andrew A Raubischek

6

0 references

Anna M Wu

7

0 references

Peter J Hudson

8

0 references

language of work or name

0 references

publication date

14 February 2003

0 references

Journal of Molecular Biology

0 references

326

0 references

2

0 references

341-51

0 references

Design and application of diabodies, triabodies and tetrabodies for cancer targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Methods for generating multivalent and bispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Improving the efficacy of antibody-based cancer therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Recombinant antibodies for cancer diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Tumor targeting of mono-, di-, and tetravalent anti-p185(HER-2) miniantibodies multimerized by self-associating peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

New protein engineering approaches to multivalent and bispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Delivery of the alpha-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

ScFv multimers of the anti-neuraminidase antibody NC10: shortening of the linker in single-chain Fv fragment assembled in V(L) to V(H) orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Crystal structure of a diabody, a bivalent antibody fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Three-dimensional structures of single-chain Fv-neuraminidase complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

A reference of the GOLD classification of monoclonal antibodies against carcinoembryonic antigen to the domain structure of the carcinoembryonic antigen molecule.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Stereochemical criteria for polypeptide and protein chain conformations. II. Allowed conformations for a pair of peptide units

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

PROCHECK: a program to check the stereochemical quality of protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Three-dimensional structure of an Fv from a human IgM immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Canonical structures for the hypervariable regions of immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Structural repertoire of the human VH segments

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Standard conformations for the canonical structures of immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Conformations of the third hypervariable region in the VH domain of immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Structural classification of CDR-H3 in antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Domain association in immunoglobulin molecules. The packing of variable domains

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Structural invariants of antigen binding: comparison of immunoglobulin VL-VH and VL-VL domain dimers

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Recombinant anti-sialidase single-chain variable fragment antibody. Characterization, formation of dimer and higher-molecular-mass multimers and the solution of the crystal structure of the single-chain variable fragment/sialidase complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Structural models for carcinoembryonic antigen and its complex with the single-chain Fv antibody molecule MFE23

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

A phage library-derived single-chain Fv fragment in complex with turkey egg-white lysozyme: characterization, crystallization and preliminary X-ray analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Geometric invariant core for the V(L) and V(H) domains of immunoglobulin molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Orientation of antigen binding sites in dimeric and trimeric single chain Fv antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Site-specific conjugation of DOTA-peptides to a Cys-diabody

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Crystallographic structure of an intact IgG1 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

An extensively modified version of MolScript that includes greatly enhanced coloring capabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Raster3D Version 2.0. A program for photorealistic molecular graphics

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Determination of protein molecular weight, hydration, and packing from crystal density

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Processing of X-ray diffraction data collected in oscillation mode

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

AMoRe: an automated package for molecular replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Improved methods for building protein models in electron density maps and the location of errors in these models

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Cross-validated maximum likelihood enhances crystallographic simulated annealing refinement

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

"Diabodies": small bivalent and bispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

A very limited number of keywords (main patterns) describes all sequences of the human variable heavy (VH) and kappa (Vkappa) domains

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2901428-6

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27640402&oldid=1373893340"